Objective: L-Aspartate is an important intermediary metabolite in the heart and has also been implicated in myocardial protection, but little is known about its transport across the cardiac sarcolemma. In this study we have tested the hypothesis that the high affinity sodium-dependent aspartate transporter, EAAC-1 is expressed in heart and have also characterised aspartate transport into the 14 myocardium. Methods: Characteristics of L-[ C]aspartate uptake into rat heart were investigated using sarcolemmal vesicles and isolated myocytes. The expression of EAAC-1 in the two preparations was also investigated by western blotting. Results: The K and V of m m a x L-aspartate uptake was 9.7860.7 mM and 1.1760.27 pmol / mg / s in vesicles compared to 6.5361.24 mM and 13.6561.0 pmol / ml/s in cells. In vesicles, L-aspartate uptake was dependent on external sodium and internal potassium, and was rheogenic. In cells, L-aspartate uptake was also dependent on external sodium. Addition of unlabelled L-and D-aspartate and L-glutamate significantly inhibited 14 L-[ C]aspartate uptake in both preparations but D-glutamate had no effect. An antibody to the aspartate transporter, EAAC-1 recognised a protein of appropriate size in both vesicles and cells. Conclusions: L-aspartate uptake in heart is mediated by a high affinity sodium-dependent transporter. This is accompanied by the expression in heart of EAAC-1. The physiological significance of this transporter with respect to aspartate utilisation in the heart is discussed.
Introduction
led to the strategy of enriching crystalloid cardioplegia solutions with aspartate and other amino acids to provide The dicarboxylic amino acid, aspartate plays an immyocardial protection during coronary artery bypass portant role in intermediary metabolism in the heart. For surgery [4] . example it is a major participant in the malate-aspartate
The efficiency of L-aspartate to perform these tasks will shuttle, which is critical to the transfer of reducing be dependent upon its intracellular concentration in the equivalents produced in the cytoplasm through glycolysis heart. This in turn is likely to be influenced by the rate of and the oxidation of lactate into the mitochondria [1] .
L-aspartate transport across the cardiac sarcolemma. At Another essential function of L-aspartate in heart is to act present, there is little known about the characteristics of as an anaplerotic substrate to counteract disturbances in the L-aspartate flux into and out of heart cells. It is known that concentration of TCA cycle intermediates [2] . This can the RNA for the glutamate aspartate transporter EAAC-1 is happen as a result of loading with glucose, acetate, ketone present in heart [5, 6] , but crucially this does not give any bodies or fatty acids, or under pathological conditions such indication of the level of protein expression or the amount as on aerobic arrest and during ischaemia [3] . Indeed it is of any functional activity. this potential for supporting cardiac metabolism that has This study is based on the hypothesis that an aspartate transporter is present and active in rat cardiac sarcolemma. To test this the characteristics of L-aspartate transport were *Corresponding author. Tel.: 144-1179-283-587; fax: 144-1179-283-581.
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investigated using sarcolemmal vesicles and isolated car-2.2. Preparation of cardiac sarcolemmal vesicles and 14 diac myocytes, which were both prepared from the rat measurement of L-[ C]aspartate uptake heart. This dual approach has the advantage that the cardiac sarcolemmal vesicles do not contain organelles Homogenisation and differential centrifugation was used [7, 8] and therefore the measurements will not be affected to prepare the cardiac sarcolemmal vesicles [7, 8] . In brief, by metabolism. Also, it is possible to control both the the ventricles from eight rat hearts (wet weight 6.8660.26 internal and external environment of the vesicles thereby g, n5286S.E.M.) were finely minced with scissors and simplifying experiments investigating the effects of spethen suspended 3-4 times weight for volume in a solution cific ion gradients or of changing the membrane potential containing (in mM) 300 sucrose, 5 MgSO , 0.1 phenyl-4 difference. These investigations are then complemented by methylsulphonyl fluoride (PMSF) and 10 imidazole-HCl the use of the isolated cardiac myocytes, where intracellu-(pH 7.0). The suspension was homogenised with 435-s lar metabolism of aspartate was prevented by the addition bursts at full power using an Ystral X-1020. Then, 500 ml of amino-oxyacetate. In addition and perhaps more imof the homogenate was immediately frozen for use in portantly once the transport under normal conditions has enzyme assays, whilst the sucrose concentration of the been characterised, the isolated cardiac myocytes can then remaining homogenate was adjusted to 600 mM using a be used in future studies to examine the effects of different 2-M sucrose stock. The mix was stirred on ice for 15 min pathological conditions. Finally, with the knowledge then centrifuged at 30 0003g and 48C for 30 min. The gained from these experiments the expression of a candisupernatant was diluted 1. representing the purified sarcolemmal vesicles was susgton type I, was from Worthington Biochemical Corporapended in 700 ml of solution 1. Finally, 200 ml of the tion (Lakewood, NJ, USA); dinonylphthalate was from sarcolemmal vesicles were frozen for use in enzyme Fluka (Glossop, Derbyshire, UK) and N-glycosidase F was assays, whilst the remaining sample was stored at 2808C from Calbiochem (Beeston, Nottinghamshire, UK). Other until use. chemicals were from either BDH or Sigma and were of
The purity of the vesicle preparation was assessed from analytical grade.
the activity, enrichment and percentage recovery of marker Tissue used in this study was obtained from male Wistar enzymes in comparison to samples of crude homogenate, rats (250-300 g body weight). The rats were humanely as shown in Table 1 [9] . All the vesicle preparations which killed by cervical dislocation, with the hearts either used were used in experiments had a significantly greater for the preparation of cardiac sarcolemmal vesicles or the enrichment and percentage recovery of the sarcolemmal 1 1 isolation of cardiac myocytes, and the kidneys used to marker, Na ,K ATPase compared to the marker for the 21 1 prepare brush-border membrane vesicles (BBMV). This sarcoplasmic reticulum, Ca (K )ATPase. The enrich- was observed (Table 1) . This was consistent with previous HEPES-Tris (pH 7.4), by three rounds of centrifugation at measures of enzyme activities in cardiac sarcolemmal 9003g and room temperature followed by suspension of vesicles, which were prepared using this method [7, 8] .
the pellet in fresh media. The resulting pellet was pre-equilibrated with either (in centration and H O was mixed with 100 ml of the cell 2 mM) 300 mannitol, 10 HEPES-Tris (pH 7.4) or 100 K suspension. The mixture was pipetted into a small Eppengluconate, 100 mannitol, 10 HEPES-Tris (pH 7.4) 6 100 dorff tube preloaded with 75 ml of a silicone / dimg valinomycin per mg of vesicle protein using freeze nonylphthalate mix at a ratio of 70:30 (v / v), layered over thaw fractionation [11] . Experiments were then started by 50 ml of 10% (v / v) HClO containing 25% (w / v) glycerol. ice cold solution containing 150 mM NaCl and 10 mM special tool (BDH). Each vial was thoroughly mixed by HEPES (pH 7.4 with Tris) before being processed for vortex before being processed for liquid scintillation liquid scintillation counting. Controls were taken for zero counting.
14 time and non-specific binding of the isotope to the filters. In experiments where the rate of L-[ C]aspartate uptake In most cases, the transport media contained (in mM) into the cells was measured this was carried out using first 100 NaCl or choline Cl, 100 mannitol, 10 HEPES / Tris order rate plots [14] . These were calculated according to 14 (pH 7.4) and 10 mM ing the sensitivity of L-[ C]aspartate uptake to amino acid measured (taken as the uptake at 30 min, which was inhibitors, where 100 mM of each putative inhibitor was 248.2868.5 pmol / ml in NaCl containing media and added (equivalent to a ten-fold excess when compared to 68.2568.5 pmol / ml for the sodium dependent component, 14 14 all n556S.E.M.) and asp was L-[ C]aspartate uptake at the L-[ C]aspartate concentration). t time t min, as shown in Fig. 4 . Thus in subsequent Initial rate measurements were made at 1 s. To do this, 14 experiments investigating the kinetics of L-[ C]aspartate the basic method [12] was modified, so that 940 ml of an uptake these rates were evaluated from uptakes measured ice cold stop solution containing (in mM) 150 Na-glucoat intervals over the first 0.5 min using plots similar to that nate, 10 HEPES-Tris (pH 7.4) was added directly to tubes shown in Fig. 4 . containing 60 ml of the vesicles and transport solution. The
Results from the isolated cardiac myocytes are extubes were then placed on ice before being filtered and pressed as pmol / ml (i.e in terms of the cell space or washed with an additional 233 ml ice-cold stop solution.
volume). To determine the intracellular space or volume 14 3 the uptake of 1 mM cardiac sarcolemmal vesicles was rheogenic was investi-X-ray films were visualised on a BioRad scanning densigated by measuring the initial rate in the presence or tometer (BioRad Laboratories, Hemel Hempstead, UK) absence of valinomycin. Fig. 2 N-glycosidase F treatment of the cardiac myocytes, valinomycin had no effect on L-[ C]aspartate uptake (not cardiac sarcolemmal vesicles and BBMV was carried out shown). according to the method of Tarentino et al. [16] . In brief, Fig. 3 shows the kinetics of the sodium dependent samples containing 100 mg protein were added to a tube component (calculated as the uptake in NaCl minus the 14 containing 50 mM sodium phosphate (pH 7.5), 0.1 mM uptake in choline Cl) of L-[ C]aspartate uptake into PMSF, 10% Nonidet P-40, and 16.6 mU / ml N-glycosidase potassium loaded vesicles. In the main graph the initial rate 14 F and incubated at 308C for 1.5 h. The tubes were then of uptake for a range of L-[ C]aspartate concentrations centrifuged at 15 8003g for 1 min with the resulting pellet between 2 and 300 mM is shown. The initial rate of uptake suspended in 50 mM sodium phosphate solution (pH 7.5).
increased linearly in proportion to the substrate concenThen, 20 ml of this suspension was then added to 10 ml tration until 30 mM when saturation occurred. This data loading solution and used directly for western blotting as represented a good fit to the Michaelis-Menten equation 
Discussion
the uptake in the presence of valinomycin (Student's t-test). Data shown were means6S.E.M. of n55 vesicle preparations.
In this study we have investigated the hypothesis that there is an active L-aspartate transporter in the rat heart. To 14 do this we have characterised L-[ C]aspartate uptake using sarcolemmal vesicles and isolated cardiac myocytes and 14 [ C]aspartate the apparent rate constant in sodium-conhave investigated the expression of a candidate aspartate 14 taining media was 1.49 / min and the rate of L-[ C]aspartransporter, namely EAAC-1 in both preparations. tate uptake was 318.86615.79 pmol / ml / min (n5 In vesicles L-aspartate uptake was dependent on an 56S.E.M.), whilst for the sodium-dependent component inward sodium gradient and an outward potassium grathe apparent rate constant was 1.3 / min and the rate of dient. This was apparent from the greater magnitude of 14 L-[ C]aspartate uptake was 68.5613.78 pmol / ml / min L-aspartate uptake under these conditions compared to no (n556S.E.M.).
inward sodium gradient and no outward potassium gradient Fig. 5 shows the kinetics of the sodium-dependent and the occurrence of an overshoot. At equilibrium, the 14 14 component of L-[ C]aspartate uptake into the cells, which level of uptake reflects an equal movement of L-[ C]aswas measured over a concentration range of 2-1000 mM.
partate into and out of the vesicle. The greater level of 14 14 The initial rate of L-[ C]aspartate increased in proportion uptake at earlier time points indicates that L-[ C]aspartate to the concentration up to 20 mM. After this a plateau was accumulation into the vesicles has occurred against a 14 reached, where the rate of L-[ C]aspartate uptake did not concentration gradient. Eventually, the dissipation of the significantly change for concentrations up to 1000 mM inward sodium gradient removes the driving force for (uptakes for concentrations between 300 and 1000 mM are L-aspartate uptake and the L-aspartate equilibrates. This not shown for reasons of clarity). From this a K of dependence upon external sodium and internal potassium b-hydroxyaspartate compared to L-a-aminoadipate has also present in the rat cardiac sarcolemma. Indeed all of the been described for the high affinity glutamate aspartate transport characteristics described here for the heart cells transporters and EAAC-1 in particular [5, 18, 19] .
and vesicles are very consistent with the transport propThere was a strong similarity between these characteriserties, which have been reported for EAAC-1 [5, 6, [17] [18] [19] ].
2 tics of L-aspartate uptake in vesicles compared to cells. In The expression of the system X transporter, EAAC-1 ag cells L-aspartate uptake was also sodium-dependent, [5, 6] in both cells and vesicles may suggest that this showed the identical sensitivity to dicarboxylic amino transporter is responsible for L-aspartate transport in heart. acids, and had a K of 6.5361.24 mM. Taken together the It should be noted however that this does not exclude the also participate in L-aspartate transport [17] . The most centration gradient would be 12.5 kJ / mol (calculated using likely explanation for the slightly smaller molecular weight the equation upper panel) was differences in the glycosylation pattern extracellular concentrations, respectively). This could easiof the two samples. This was apparent from the similarity ly be met by the energy available from the sodium in the molecular weight of EAAC-1 in the cells and electrochemical gradient which is 28 kJ / mol assuming that vesicles following treatment with N-glycosidase F (Fig. 6 , the stoichiometry in heart is similar to that reported for lower panel). During vesicle preparation outer and inner L-aspartate transport in other tissues [5, 6, [16] [17] [18] , i.e. 2 cell membranes were disrupted [7, 8] , which most likely sodium to 1 aspartate. caused the release of various enzymes including Unlike L-aspartate, where little was known about its glycosylases. These intracellular enzymes are not liberated transport in the myocardium, the uptake of another diduring cell isolation [13] .
carboxylic amino acid L-glutamate uptake has been studied The dependence of L-aspartate flux across the cardiac in cardiac sarcolemmal vesicles. In one study L-glutamate sarcolemma on an inward sodium gradient and an outward uptake did not overshoot; was not stimulated by internal potassium gradient is important, because this will permit potassium and had a K of 149640 mM [21] . Another m the inward flux of L-aspartate into heart cells against the study, which was reported as an abstract only, showed a large tissue to plasma concentration gradient that exists in K of 240640 mM for L-glutamate uptake into pig cardiac m vivo. The intracellular myocardial concentration of asparsarcolemmal vesicles and inhibition by D-glutamate [22] . tate is usually around 100-fold greater than the concenClearly these characteristics of L-glutamate uptake are tration found in the cardiac circulation [20] . Under normal quite distinct to those described here for L-aspartate uptake. conditions, the energy required to maintain such a conHowever, whether these differences are due to species
